H.C. Wainwright Flag KRRO-121 as Independent Value Driver for Korro Bio, Inc. (KRRO)
TheFly reported on January 29 that H.C. Wainwright upgraded KRRO from Neutral to Buy with a $20 price target.
Korro Bio Inc. (KRRO)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Lynx1 Capital Management Weston Nichols | 1,538,296 | $17,413,511 | +127% | 2.75% |
| 2. | Balyasny Asset Management Dmitry Balyasny | 1,040,054 | $11,773,411 | 0.02% | |
| 3. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 660,036 | $7,471,608 | +11% | 0.28% |
| 4. | ADAR1 Capital Management Daniel Schneeberger | 540,054 | $6,113,411 | 0.36% | |
| 5. | Driehaus Capital Richard Driehaus | 450,045 | $5,094,509 | 0.04% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.60 | 520 | $5,512.00 | 1,538,296 | 2026-03-31 | Filing | |
| $11.11 | 207,100 | $2,300,881.00 | 1,297,893 | 2026-03-10 | Filing | |
| $11.11 | 207,100 | $2,300,881.00 | 1,297,893 | 2026-03-10 | Filing | |
| $11.11 | 207,100 | $2,300,881.00 | 1,297,893 | 2026-03-10 | Filing | |
| $11.11 | 207,100 | $2,300,881.00 | 1,297,893 | 2026-03-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.96 | 8,506 | $118,743.76 | 146,305 | 2026-07-06 | Filing | |
| $13.96 | 817 | $11,405.32 | 706,556 | 2026-07-06 | Filing | |
| $14.03 | 14,745 | $206,872.35 | 154,811 | 2026-07-02 | Filing | |
| $14.03 | 85,955 | $1,205,948.65 | 707,373 | 2026-07-02 | Filing | |
| $14.98 | 114 | $1,707.72 | 169,556 | 2026-06-24 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 861 | $11,348 | 0% | |
| 2. | 539 | $7,104 | 0% |
News See All
20 Best Biotech Stocks Under $20 to Buy Now
The U.S. biotechnology market enters 2026 as the largest global biotech market, with an estimated size of $552.39 billion in 2023, and is projected to grow to $1.24 trillion by 2030.
5 Most Promising Small-Cap Stocks According to Analysts
In this piece, we will take a look at the five most promising small-cap stocks according to analysts.
Hedge Fund Resource Center